Related references
Note: Only part of the references are listed.Pharmacological methyl group donors block skeletal metastasis in vitro and in vivo
Nicholas Shukeir et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applications
Surabhi Parashar et al.
CANCER MEDICINE (2015)
S-Adenosylmethionine and Methylthioadenosine Inhibit beta-Catenin Signaling by Multiple Mechanisms in Liver and Colon Cancer
Tony W. H. Li et al.
MOLECULAR PHARMACOLOGY (2015)
The methyl donor S-adenosylmethionine potentiates doxorubicin effects on apoptosis of hormone-dependent breast cancer cell lines
Concetta Paola Ilisso et al.
ENDOCRINE (2015)
Correlation between ERK1 and STAT3 expression and chemoresistance in patients with conventional osteosarcoma
Sebastien Salas et al.
BMC CANCER (2014)
DNA methylation regulates expression of VEGF-C, and S-adenosylmethionine is effective for VEGF-C methylation and for inhibiting cancer growth
M. X. Da et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2014)
Synergistic anti-breast cancer effect of a combined treatment with the methyl donor S-adenosyl methionine and the DNA methylation inhibitor 5-aza-2-deoxycytidine
Flora Chik et al.
CARCINOGENESIS (2014)
Wnt Pathway in Osteosarcoma, from Oncogenic to Therapeutic
Yu Cai et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2014)
New Horizons for Old Drugs and Drug Leads
Gordon M. Cragg et al.
JOURNAL OF NATURAL PRODUCTS (2014)
p21Waf1/Cip1 deficiency causes multiple mitotic defects in tumor cells
N-N Kreis et al.
ONCOGENE (2014)
TRAF4 Enhances Osteosarcoma Cell Proliferation and Invasion by Akt Signaling Pathway
Weitao Yao et al.
ONCOLOGY RESEARCH (2014)
The balance between cell cycle arrest and cell proliferation: control by the extracellular matrix and by contact inhibition
Claude Gerard et al.
INTERFACE FOCUS (2014)
Methionine salvage and S-adenosylmethionine: essential links between sulfur, ethylene and polyamine biosynthesis
Margret Sauter et al.
BIOCHEMICAL JOURNAL (2013)
New molecular insights into osteosarcoma targeted therapy
Jilong Yang et al.
CURRENT OPINION IN ONCOLOGY (2013)
Inorganic Phosphate as a Signaling Molecule: A Potential Strategy in Osteosarcoma Treatment
Annamaria Spina et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma
Lei Chen et al.
FEBS LETTERS (2013)
The possible use of inorganic phosphate in osteosarcoma therapy
Silvio Naviglio
FUTURE ONCOLOGY (2013)
S-adenosylmethionine, a methyl donor, up regulates tissue inhibitor of metalloproteinase-2 in colorectal cancer
Z. Hussain et al.
GENETICS AND MOLECULAR RESEARCH (2013)
The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines
Claudia M. J. Lucero et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway
Annamaria Spina et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Effects of S-adenosylmethionine and methylthioadenosine on inflammation-induced colon cancer in mice
Tony W. H. Li et al.
CARCINOGENESIS (2012)
S-Adenosyl-Methionine-Dependent Methyltransferases: Highly Versatile Enzymes in Biocatalysis, Biosynthesis and Other Biotechnological Applications
Anna-Winona Struck et al.
CHEMBIOCHEM (2012)
Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy
Libero Santarpia et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
S-Adenosylmethionine Inhibits the Growth of Cancer Cells by Reversing the Hypomethylation Status of c-myc and H-ras in Human Gastric Cancer and Colon Cancer
Jin Luo et al.
International Journal of Biological Sciences (2012)
S-adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utility
Quentin M. Anstee et al.
JOURNAL OF HEPATOLOGY (2012)
S-ADENOSYLMETHIONINE IN LIVER HEALTH, INJURY, AND CANCER
Shelly C. Lu et al.
PHYSIOLOGICAL REVIEWS (2012)
The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines
Stacey L. Fossey et al.
BMC CANCER (2011)
Delivering affordable cancer care in high-income countries
Richard Sullivan et al.
LANCET ONCOLOGY (2011)
STAT3 SIGNALING: Anticancer Strategies and Challenges
Paul A. Johnston et al.
MOLECULAR INTERVENTIONS (2011)
The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy
Stephen L. Abrams et al.
CELL CYCLE (2010)
Structure-function relationships in methionine adenosyltransferases
G. D. Markham et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Conformational signals in the C-terminal domain of methionine adenosyltransferase I/III determine its nucleocytoplasmic distribution
Edel Reytor et al.
FASEB JOURNAL (2009)
Regulation of glutathione synthesis
Shelly C. Lu
MOLECULAR ASPECTS OF MEDICINE (2009)
Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways
Ymera Pignochino et al.
MOLECULAR CANCER (2009)
S-Adenosylmethionine and Methylthioadenosine Inhibit Cellular FLICE Inhibitory Protein Expression and Induce Apoptosis in Colon Cancer Cells
Tony W. H. Li et al.
MOLECULAR PHARMACOLOGY (2009)
S-adenosylmethionine and proliferation: new pathways, new targets
Nuria Martinez-Lopez et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
The Radical SAM Superfamily
Perry A. Frey et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)
Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy
Doris Germain et al.
CLINICAL CANCER RESEARCH (2007)
Role of methionine adenosyltransferase 2A and S-adenosylmethionine in mitogen-induced growth of human colon cancer cells
Hui Chen et al.
GASTROENTEROLOGY (2007)
Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo
Nicholas Shukeir et al.
CANCER RESEARCH (2006)
Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol-associated liver cancer
SC Lu et al.
ALCOHOL (2005)
S-adenosylmethionine:: nothing goes to waste
M Fontecave et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Deadly conversations: Nuclear-mitochondrial cross-talk
VL Dawson et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2004)
Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis
P Pakneshan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
S-adenosylmethionine and its metabolite induce apoptosis in HepG2 cells:: Role of protein phosphatase 1 and Bcl-xS
HP Yang et al.
HEPATOLOGY (2004)
Stabilization of S-adenosyl-L-methionine promoted by trehalose
A Morana et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2002)
S-Adenosylmethionine and methylthioadenosine are antiapoptotic in cultured rat hepatocytes but proapoptotic in human hepatoma cells
E Ansorena et al.
HEPATOLOGY (2002)
S-adenosylmethionine: a control switch that regulates liver function
JM Mato et al.
FASEB JOURNAL (2002)
S-Adenosylmethionine
SC Lu
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2000)
Share Paper
